Virginia Pajares, Alfons Torrego, Elisabeth Martínnez-Téllez, Juan Carlos Trujillo-Reyes

Pajares et al. J Clin Transl Res 2020; 6(S4):1

Published online: September 2, 2020

Abstract

The diagnosis and staging of lung cancer is an important process that identifies treatment options and guides disease prognosis. Therefore, an accurate mediastinal lymph node staging is required not only to offer the appropriate treatment but also to avoid unnecessary invasive procedures. Currently, EBUS-TBNA is the preferred modality for sampling mediastinal lymph nodes because of its minimally invasive nature and high diagnostic yield. In this review, we discuss the utility of EBUS in mediastinal lymph node staging of of non-small cell lung cancer (NSCLC).

Relevance for patients: The use of EBUS-TBNA in the diagnosis of mediastinal and hilar lymph node pathology has become in an essential endoscopic technique and the first step for staging of lung cancer. 

DOI: http://dx.doi.org/10.18053/jctres.06.2020S4.001

Author affiliation

1. Respiratory Medicine. Hospital de la Santa Creu i Sant Pau. Barcelona.
2. Biomedical Research Institute Sant Pau (IIB-Sant Pau). Barcelona.
3. Thoracic Surgery Department. Hospital de la Santa Creu i Sant Pau. Barcelona.

*Corresponding author:
Virginia Pajares Ruiz,
Respiratory Medicine. Hospital de la Santa Creu i Sant Pau C/ Sant Antoni Mª Claret, 167. CP: 08025. Barcelona (Spain)
Tel: +34935565972.
Fax: +34935565601
Email: vpajares@santpau.cat

Handeling editor:
Felipe Couñago
Oncologic Group for the Study of Lung Cancer, Spanish Radiation Oncology Society
Radiation Oncology Department, Hospital Universitario Quirónsalud Madrid; Hospital La Luz, Madrid; Universidad Europea de Madrid, Spain

Downloads

Epub ahead of print (643.9 KB)